Enovix (NASDAQ:ENVX) Cut to “Market Perform” at William Blair

William Blair lowered shares of Enovix (NASDAQ:ENVX) from an outperform rating to a market perform rating in a report published on Monday, Marketbeat reports.

A number of other research analysts have also recently commented on ENVX. Oppenheimer lowered their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a report on Thursday, May 14th. TD Cowen cut their price objective on shares of Enovix from $7.00 to $5.50 and set a “hold” rating for the company in a report on Friday, July 24th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. Finally, JPMorgan Chase & Co. downgraded shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $11.77.

Enovix Price Performance

NASDAQ:ENVX opened at $3.40 on Monday. The business’s 50-day simple moving average is $5.13 and its two-hundred day simple moving average is $5.78. Enovix has a 52 week low of $3.06 and a 52 week high of $14.21. The stock has a market cap of $746.13 million, a PE ratio of -4.20 and a beta of 2.32. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46.

Enovix (NASDAQ:ENVX) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The firm had revenue of $9.02 million during the quarter, compared to analyst estimates of $8.43 million. During the same quarter in the prior year, the company posted ($0.13) earnings per share. The business’s quarterly revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, analysts forecast that Enovix will post -0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Enovix

Large investors have recently bought and sold shares of the business. Private Advisor Group LLC raised its stake in Enovix by 2.7% during the third quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock valued at $464,000 after purchasing an additional 1,242 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares in the last quarter. Equitable Holdings Inc. increased its holdings in shares of Enovix by 10.9% in the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after buying an additional 1,342 shares during the last quarter. NewEdge Advisors LLC increased its holdings in shares of Enovix by 4.7% in the 1st quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock worth $215,000 after buying an additional 1,853 shares during the last quarter. Finally, Mariner LLC increased its holdings in shares of Enovix by 3.4% in the 3rd quarter. Mariner LLC now owns 58,343 shares of the company’s stock worth $582,000 after buying an additional 1,921 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Buy upgrade and improving estimates: Zacks upgraded Enovix to Rank #2 (Buy), citing growing optimism about the company’s earnings outlook. Separately, Zacks said ENVX is technically oversold after a steep four-week decline, while analysts have been revising earnings estimates higher—factors that could support a near-term rebound. Enovix upgraded to Buy Why Enovix’s trend might reverse
• Positive Sentiment: CEO transition described as strategic continuity: Enovix said the leadership change is a “CEO transition, not a strategy transition,” reaffirmed its third-quarter 2026 guidance, and reported approximately $552 million in cash. The sizable cash balance may ease near-term financing concerns and support continued development. Enovix CEO transition webcast
• Neutral Sentiment: Unusually high trading activity in Enovix call options indicates elevated speculative interest, but the report does not establish whether investors are positioning for a sustained rally or further volatility. Enovix call option activity
• Negative Sentiment: Analyst downgrade and recent low: William Blair cut ENVX to Market Perform, and the stock recently reached a new 12-month low after the downgrade. Reports also attributed the broader decline in battery-development stocks to sharply higher Treasury yields, which pressure speculative companies. William Blair downgrades Enovix Higher yields pressure speculative growth stocks

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.